Trial intelligence / Profile preview

Dexmedetomidine +/- Dexamethasone for PONV in Breast Cancer

NCT02550795Completed

Sponsor
Gachon University Gil Medical Center
Start
Sep 2015
Primary completion
Aug 2016
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of dexmedetomidine in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Gachon University Gil Medical Center. Primary endpoint: Postoperative Nausea (Numeric Rating Scale). Started Sep 2015; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT02550795.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02550795.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call